Clinical trials
Recruiting Atherosclerosis trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 3 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| AstraZeneca | 1 |
| CSL Behring | 1 |
| Eli Lilly and Company | 1 |
| Hospital do Coracao | 1 |
| Instituto Nacional de Cardiologia de Laranjeiras | 1 |
| Novartis Pharmaceuticals | 1 |
| University of Sao Paulo General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 8 |
| Coronary Artery Disease | 3 |
| Cardiovascular Diseases | 1 |
| Coronary Occlusion | 1 |
| Diabetes Mellitus | 1 |
| Hypercholesterolemia | 1 |
| Inflammation | 1 |
| Kidney Failure, Chronic | 1 |
| Myocardial Infarction | 1 |
| Obesity | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.